These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9304342)

  • 1. [The development and clinical evaluation of the probiotic Bifidumbacterin forte].
    Grigor'ev AV; Bondarenko VM; Abramov NA; Murashova AO; Feklisova LV; Chuprinina RP
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (3):92-6. PubMed ID: 9304342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The regulation of microecological disorders of the intestines in newborn infants with perinatal pathology using the new probiotic bifidumbacterin-forte].
    Iakushenko MN; Tkhagapsoeva ZhM; Bondarenko VM
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (6):18-22. PubMed ID: 9460858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment efficacy in acute intestinal infections, chronic diseases of the gastrointestinal tract and viral hepatitis B using large doses of Russian Bifidumbacterin-forte].
    Gracheva NM; Shcherbakov IT; Avakov AA; Matsulevich TV
    Voen Med Zh; 1999 May; 320(5):51-7, 96. PubMed ID: 10401251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The microecological disorders in clinical pathology and their correction by bifidum-containing probiotics].
    Vorob'ev AA; Bondarenko VM; Lykova EA; Grigor'ev AV; Matsulevich TM
    Vestn Ross Akad Med Nauk; 2004; (2):13-7. PubMed ID: 15101202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impaired interferon status in children with acute respiratory infection and its correction with bifidumbacterin-forte].
    Lykova EA; Vorob'ev AA; Bokovoĭ AG; Murashova AO
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (2):65-7. PubMed ID: 11548264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of loading doses of bifidumbacterin forte for treatment of patients with acute enteric infections].
    Korviakova EP
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (6):58-61. PubMed ID: 11210639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Principles of constructing synbiotic preparations, and evaluation of their clinical effectiveness].
    Amerkhanova AM; Aleshkin VA; Gracheva NM; Petrova MS; Popova OP; Zubkova ES; Zhilenkova OG; Kuralenko AA; Solov'eva AI
    Vestn Ross Akad Med Nauk; 2006; (6):38-44. PubMed ID: 16869260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The probiotic correction of microecological and immune disorders in gastroduodenal pathology in children].
    Lykova EA; Bondarenko VM; Izachik IuA; Izachik NA; Grigor'ev AV; Murashov AO; Abramov NA
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):88-91. PubMed ID: 8701669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The efficacy of the eubiotic bifacide when used in the combined antibacterial therapy of newborn infants with infectious-inflammatory diseases].
    Kushnareva MV; Dement'eva GM; Chernonog IN; Frolova MI; Feklisova LV; Rebrova TN
    Antibiot Khimioter; 1996; 41(11):28-32. PubMed ID: 9214283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experience of pediatric application of bifidumbacterin multi, a biologically active food supplement].
    Amerkhanova AM; Lavrova AE; Dmitrieva GV; Pyrikova IA; Zubkova ES; Zhilenkova OG; Kuralenko AA
    Vestn Ross Akad Med Nauk; 2005; (12):30-2. PubMed ID: 16404980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disruption of microbiocenosis of the large intestine and the immune and interferon status in children with bacterial complications of acute viral infections of the respiratory tract and their correction by high doses of bifidumbacterin forte].
    Lykova EA; Vorob'ev AA; Bokovoĭ AG; Pobedinskaia IN; Gevondian VS; Gevondian NM; Mitrokhin SD; Minaev VI; Dzis NB; Makkaveeva LF; Kovalev IV; Murashova AO; Bondarenko VM
    Antibiot Khimioter; 2000; 45(10):22-7. PubMed ID: 11212396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bacterial endotoxinemia in children with intestinal dysbacteriosis].
    Lykova EA; Bondarenko VM; Vorob'ev AA; Sudzhan EV; Minaev VI; Malikov VE
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):67-70. PubMed ID: 10851996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Importance of the eradication of the focus of infection and the synchronized correction of disturbed intestinal microflora in shigellosis patients].
    Shakhmardanov MZ; Bondarenko VM; Isaeva NP
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (6):71-3. PubMed ID: 9949508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined antibacterial and probiotic therapy of Helicobacter-associated diseases in children].
    Lykova EA; Bondarenko VM; Sidorenko SV; Grishina ME; Murashova AO; Minaev VI; Rytikov FM; Korsunskiĭ AA
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (2):76-81. PubMed ID: 10356744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical manifestations and treatment of intestinal dysbacteriosis in patients with Flexner's dysentery].
    Shakhmardanov MZ; Luchshev VI; Bondarenko VM; Isaeva NN
    Klin Med (Mosk); 1997; 75(7):47-9. PubMed ID: 9411056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The immunocorrective properties of bacterial preparations (lactobacterin, bifidumbacterin) and bemitil in pregnant women with a urogenital infection].
    Dolgushina VF
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Apr; (4):56-8. PubMed ID: 1882611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: bifidobacteria as probiotic agents -- physiological effects and clinical benefits.
    Picard C; Fioramonti J; Francois A; Robinson T; Neant F; Matuchansky C
    Aliment Pharmacol Ther; 2005 Sep; 22(6):495-512. PubMed ID: 16167966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy of using an immune lactoglobulin preparation for correcting intestinal dysbacteriosis in newborn infants].
    Kushnareva MV; Keshishian ES; Soboleva SV
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (2):101-4. PubMed ID: 7653120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of bacterial preparations bifidumbacterin and bificol in the treatment of chronic enterocolitis complicated by dysbacteriosis].
    Krums LM; Zhukovskaia NA; Semenova LP; Goncharova GI; Pospelova VV
    Ter Arkh; 1975; 47(8):86-9. PubMed ID: 1188656
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of bifidumbacterin for the correction of intestinal dysbacteriosis].
    Liz'ko NN; Goncharova GI
    Kosm Biol Aviakosm Med; 1987; 21(4):70-2. PubMed ID: 3657069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.